leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 02:16:23 - browse：8961

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Neuroscience startup Neumora files for IPO

WSS

Why Marc Tessier

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

FDA panel gives mixed vote on blood pressure devices

Study finds new variant for Parkinson’s in African populations

In science, is the line between industry and academia shifting?

Drug firms test therapies to halt Alzheimer’s before symptoms arise

hotspot

leisure time

entertainment

What does generative AI mean for health care? We asked experts

Feds fine Medicare Advantage plans for overcharging members

23andMe had bad news about my health. I wish a person had delivered it

A former Republican legislative candidate has been charged for his role in the US Capitol riot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What do new weight loss drugs mean for bariatric surgery?

Medicare proposal to cover medical devices draws a mixed reaction

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

DIEP, the 'gold standard' of breast reconstruction, is under threat

How Long Island became the ‘eugenics capital of the world’

hotspot

Apellis safety probe of eye disease drug centers on injection needle

How Long Island became the ‘eugenics capital of the world’

How a symptom of dementia informs our understanding of creativity

Why Marc Tessier

Hey, doctors: Don't be no

Listen: BridgeBio's big week & Lilly's Alzheimer's data

focus

Wikipedia

focus

entertainment